Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Total article views   HTML views PDF downloads Totals
7,463 Dovepress* 6,574+ 831 7,405
PubMed Central* 889 353 1,242
Totals 7,463 1,184 8,647
*Since 8 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar